loadpatents
name:-0.032912969589233
name:-0.016161918640137
name:-0.0039970874786377
Paul; Dharam Patent Filings

Paul; Dharam

Patent Applications and Registrations

Patent applications and USPTO patent grants for Paul; Dharam.The latest application filed is for "spiropiperidine allosteric modulators of nicotinic acetylcholine receptors".

Company Profile
3.21.28
  • Paul; Dharam - Thebarton AU
  • PAUL; Dharam - Eastwood South Australia
  • Paul; Dharam - Flinders Park AU
  • Paul; Dharam - South Australia AU
  • Paul; Dharam - Torrensville N/A AU
  • Paul; Dharam - Bellfield AU
  • Paul; Dharam - Torrensville South Australia AU
  • Paul; Dharam - Victoria AU
  • Paul, Dharam - Uttaranchal IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Spiropiperidine Allosteric Modulators Of Nicotinic Acetylcholine Receptors
App 20220119351 - Bell; Ian M. ;   et al.
2022-04-21
Substituted-n-heteroaryl Compounds And Uses Thereof
App 20220112176 - Toop; Hamish ;   et al.
2022-04-14
Substituted-pyridinyl Compounds And Uses Thereof
App 20220040163 - TOOP; Hamish ;   et al.
2022-02-10
Salts, co-crystals, and polymorphs of an anxiolytic compound
Grant 10,266,529 - Flynn , et al.
2019-04-23
Amine Derivatives As Potassium Channel Blockers
App 20180273476 - Harvey; Andrew ;   et al.
2018-09-27
Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof
Grant 9,994,518 - Leavitt , et al. June 12, 2
2018-06-12
Amine derivatives as potassium channel blockers
Grant 9,914,702 - Harvey , et al. March 13, 2
2018-03-13
Salts, Co-crystals, And Polymorphs Of An Anxiolytic Compound
App 20170362230 - FLYNN; Bernard Luke ;   et al.
2017-12-21
Crystalline Form Of An Anxiolytic Compound
App 20170305905 - Flynn; Bernard Luke ;   et al.
2017-10-26
Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof-I
Grant 9,790,173 - Harvey , et al. October 17, 2
2017-10-17
Crystalline form of an anxiolytic compound
Grant 9,758,516 - Flynn , et al. September 12, 2
2017-09-12
Salts, co-crystals, and polymorphs of an anxiolytic compound
Grant 9,745,296 - Flynn , et al. August 29, 2
2017-08-29
Alpha-7 Nicotinic Acetylcholine Receptor Modulators And Uses Thereof-i
App 20170158628 - HARVEY; ANDREW ;   et al.
2017-06-08
Alpha-7 Nicotinic Acetylcholine Receptor Modulators And Uses Thereof
App 20170152221 - LEAVITT; KENNETH ;   et al.
2017-06-01
Amine Derivatives As Potassium Channel Blockers
App 20170088519 - Harvey; Andrew ;   et al.
2017-03-30
Amine derivatives as potassium channel blockers
Grant 9,493,451 - Harvey , et al. November 15, 2
2016-11-15
Salts, Co-crystals, And Polymorphs Of An Anxiolytic Compound
App 20160185770 - FLYNN; Bernard Luke ;   et al.
2016-06-30
A Crystalline Form Of An Anxiolytic Compound
App 20160039810 - FLYNN; Bernard Luke ;   et al.
2016-02-11
Amine Derivatives as Potassium Channel Blockers
App 20150299184 - Harvey; Andrew ;   et al.
2015-10-22
Methods for preparing naphthyridines
Grant 9,133,188 - Paul , et al. September 15, 2
2015-09-15
Positive Allosteric Modulators and Uses Thereof
App 20150246029 - Harvey; Andrew ;   et al.
2015-09-03
Alpha-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEROF-I
App 20150175534 - Harvey; Andrew ;   et al.
2015-06-25
Positive allosteric modulators of the .alpha.7 nicotinic acetylcholine receptor and uses thereof
Grant 9,062,013 - Harvey , et al. June 23, 2
2015-06-23
Small-molecules as therapeutics
Grant 9,023,848 - Flynn , et al. May 5, 2
2015-05-05
Amine Derivatives as Potassium Channel Blockers
App 20140336198 - Harvey; Andrew ;   et al.
2014-11-13
Methods For Preparing Naphthyridines
App 20140128600 - Paul; Dharam ;   et al.
2014-05-08
Novel Small-molecules As Therapeutics
App 20140088104 - Flynn; Bernard Luke ;   et al.
2014-03-27
Positive Allosteric Modulators of the Alpha 7 Nicotinic Acetylcholine Receptor and uses Thereof
App 20140031395 - Harvey; Andrew ;   et al.
2014-01-30
Potassium channel blockers and uses thereof
Grant 8,507,539 - Harvey , et al. August 13, 2
2013-08-13
Furo[2,3-d]pyrimidines and related compounds and methods for treating disease states by inhibiting tubulin polymerization
Grant 8,466,163 - Flynn , et al. June 18, 2
2013-06-18
Benzofuran potassium channel blockers and uses thereof
Grant 8,309,545 - Flynn , et al. November 13, 2
2012-11-13
Chromenone potassium channel blockers and uses thereof
Grant 8,217,189 - Flynn , et al. July 10, 2
2012-07-10
Aryl potassium channel blockers and uses thereof
Grant 8,202,513 - Flynn , et al. June 19, 2
2012-06-19
Novel Potassium Channel Blockers And Uses Thereof
App 20110166130 - Harvey; Andrew John ;   et al.
2011-07-07
Novel Aryl Potassium Channel Blockers And Uses Thereof
App 20100297077 - Flynn; Bernard Luke ;   et al.
2010-11-25
Novel Benzofuran Potassium Channel Blockers And Uses Thereof
App 20100087430 - Flynn; Bernard Luke ;   et al.
2010-04-08
Chemical Compounds And Processes
App 20100048591 - Flynn; Bernard Luke ;   et al.
2010-02-25
Novel Chromenone Potassium Channel Blockers And Uses Thereof
App 20090298931 - Flynn; Bernard Luke ;   et al.
2009-12-03
Process for extraction of aromatics from petroleum streams
App 20040182750 - Khanna, Mohan Krishan ;   et al.
2004-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed